6-fluoro-1H-indazol-5-amine → 4-(4-Chlorophenyl)-N-(6-fluoro-1H-indazol-5-yl)-1,2-dimethyl-6-oxo-1,4,5,6-tetrahydro-3-pyridinecarboxamide
반응식
[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([CH:8]2[CH2:13][C:12](=[O:14])[N:11]([CH3:15])[C:10]([CH3:16])=[C:9]2[C:17]([OH:19])=O)=[CH:4][CH:3]=1.[NH2:20][C:21]1[CH:22]=[C:23]2[C:27](=[CH:28][C:29]=1[F:30])[NH:26][N:25]=[CH:24]2>>[Cl:1][C:2]1[CH:3]=[CH:4][C:5]([CH:8]2[CH2:13][C:12](=[O:14])[N:11]([CH3:15])[C:10]([CH3:16])=[C:9]2[C:17]([NH:20][C:21]2[CH:22]=[C:23]3[C:27](=[CH:28][C:29]=2[F:30])[NH:26][N:25]=[CH:24]3)=[O:19])=[CH:6][CH:7]=1참가 물질
3
실험 절차
The title compound was prepared from the product of Example 56, Step 2 and 5-amino-6-fluoroindazole using the method described in Example 56, Step 3. MS (ES+) m/e 413 [M+H]+
출처 및 근거
- ORD 기록
- ord-d3d5c06177fe4c4abab0e6a2a613978d
- 출처 데이터셋
- uspto-grants-2009_09